- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07561476
Effectiveness of Matrix Rhythm Therapy for Restless Legs Syndrome (MRT-RLS)
Investigation of the Effectiveness of Matrix Rhythm Therapy in Restless Legs Syndrome: A Randomized Controlled Study
The goal of this clinical trial is to evaluate whether Matrix Rhythm Therapy (MRT), when added to a home exercise program, is effective in reducing symptoms of Restless Legs Syndrome (RLS) in adult women. It will also examine the effects of treatment on sleep quality, daytime sleepiness, depressive symptoms, and quality of life.
The main questions it aims to answer are:
Does Matrix Rhythm Therapy reduce the severity of Restless Legs Syndrome symptoms? Does Matrix Rhythm Therapy improve sleep quality and insomnia symptoms? Does Matrix Rhythm Therapy improve quality of life and emotional well-being?
Researchers compared participants receiving Matrix Rhythm Therapy plus home exercise with participants receiving home exercise alone.
Participants will:
Be randomly assigned to one of two study groups Receive a home exercise program for 5 weeks Receive Matrix Rhythm Therapy sessions twice weekly for 5 weeks if assigned to the intervention group Complete questionnaires and clinical assessments before and after treatment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Restless Legs Syndrome (RLS) is a common neurological disorder that causes uncomfortable sensations in the legs together with a strong urge to move them. Symptoms usually occur during rest, especially in the evening or at night, and may interfere with falling asleep, maintaining sleep, daytime energy, mood, and overall quality of life.
Although medications are commonly used to treat RLS, some patients experience side effects or prefer non-drug treatment options. For this reason, physical therapy and exercise-based approaches are increasingly being explored. Matrix Rhythm Therapy (MRT) is a treatment method that delivers rhythmic mechanical vibrations to soft tissues and muscles. It is intended to support circulation, tissue relaxation, mobility, and neuromuscular regulation.
The purpose of this randomized controlled study was to determine whether adding Matrix Rhythm Therapy to a home exercise program would provide greater benefit than a home exercise program alone in adults with Restless Legs Syndrome.
Eligible participants diagnosed with idiopathic Restless Legs Syndrome were randomly assigned to one of two groups:
Intervention Group: Matrix Rhythm Therapy in addition to a home exercise program Control Group: Home exercise program alone
Participants in both groups received education about lifestyle habits that may help manage RLS symptoms, including sleep hygiene, daily activity planning, and avoidance of possible triggers. Both groups also performed a structured home exercise program consisting of lower extremity stretching and strengthening exercises.
Participants assigned to the intervention group additionally received Matrix Rhythm Therapy sessions twice weekly for 5 weeks, for a total of 10 treatment sessions. Each session lasted approximately 60 minutes.
Study assessments were completed before treatment and after the 5-week intervention period. The study evaluated:
Severity of Restless Legs Syndrome symptoms Insomnia symptoms Daytime sleepiness Sleep quality Depressive symptoms Health-related quality of life
The results of this study may help determine whether Matrix Rhythm Therapy can be a useful non-pharmacological treatment option for individuals with Restless Legs Syndrome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Denizli
-
Denizli, Denizli, Turkey (Türkiye), 20070
- Pamukkale University Faculty of Physical Therapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Female participants aged 18 to 65 years Diagnosis of Restless Legs Syndrome Willingness to participate and provide informed consent Ability to comply with treatment sessions and assessments -
Exclusion Criteria:
Pregnancy Neurological or musculoskeletal disorders affecting lower extremities Severe systemic disease Current participation in another clinical study Inability to complete treatment sessions or assessments Use of medications that could significantly affect Restless Legs Syndrome symptoms
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Matrix Rhythm Therapy + Home Exercise
Participants received Matrix Rhythm Therapy in addition to a structured home exercise program.
Matrix Rhythm Therapy was applied twice weekly for 5 weeks (10 sessions total, 60 minutes each session).
|
Matrix Rhythm Therapy was applied using a certified vibration device delivering rhythmic mechanical oscillations to the lower extremity muscles.
Treatment sessions were administered according to the study protocol for participants with Restless Legs Syndrome.
Participants in the control group received a home exercise program consisting of stretching and therapeutic exercises for the lower extremities, performed according to the study protocol.
|
|
Active Comparator: Home Exercise Alone
Participants received a structured home exercise program for 5 weeks.
|
Participants in the control group received a home exercise program consisting of stretching and therapeutic exercises for the lower extremities, performed according to the study protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Restless Legs Syndrome Rating Scale
Time Frame: Baseline and 6 weeks
|
Change in Restless Legs Syndrome severity assessed using the International Restless Legs Syndrome Rating Scale
|
Baseline and 6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020SABE008 (Other Grant/Funding Number: Pamukkale University Scientific Research Projects Coordination Unit)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Restless Legs Syndrome (RLS)
-
Beijing Friendship HospitalRecruitingRestless Leg Syndrome (RLS) | Variant Restless Legs SyndromeChina
-
Wenxia JiangNot yet recruitingRestless Legs Syndrome (RLS)
-
Clinica ARS MedicaNot yet recruitingRestless Leg Syndrome (RLS)Switzerland
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)United States
-
University of Alabama at BirminghamRecruitingRestless Leg Syndrome (RLS) | Spinal Cord Stimulation (SCS)United States
-
XenoPort, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)
-
Seton Healthcare FamilyCompleted
-
GlaxoSmithKlineCompleted12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome ((CR-RLS))Restless Legs Syndrome | Restless Legs Syndrome (RLS)United States
Clinical Trials on MATRİX RHYTHM THERAPY
-
Pamukkale UniversityCompletedChronic Pain | Physical DisabilityTurkey
-
Pamukkale UniversityCompleted
-
Pamukkale UniversityCompletedSatisfaction, Patient | Hemiparesis;Poststroke/CVATurkey
-
Izmir Democracy UniversityCompletedFunctional Status | Physical PerformanceTurkey (Türkiye)
-
The University of Texas at DallasNational Institute on Deafness and Other Communication Disorders (NIDCD)Terminated
-
University of PittsburghCompletedBorderline Personality Disorder | Bipolar I DisorderUnited States
-
Mayo ClinicCompletedBipolar Disorder, Depressed
-
University of PittsburghThe Depressive and Bipolar Disorder Alternative Treatment FoundationCompletedBipolar Disorder NOSUnited States
-
University of ArizonaUnited States Department of Defense; Southern Arizona VA Health Care SystemCompletedDepression | Posttraumatic Stress Disorder | Insomnia DisorderUnited States
-
Brown UniversityThe Miriam Hospital; Michigan State University; Women and Infants Hospital of... and other collaboratorsTerminated